PORCINE SECRETIN
LOE Approachingporcine secretin
NDASUBCUTANEOUS LYOPHILIZED POWERINJECTABLEPriority Review
Approved
Apr 2002
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Priority Review
Drug data last refreshed 14h ago · AI intelligence enriched 2mo ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Porcine secretin is a peptide hormone extracted from porcine pancreatic tissue, administered as a subcutaneous lyophilized powder injection. The specific therapeutic indication is not documented in available data, limiting characterization of patient populations served. This biologic agent represents a specialized injectable therapeutic with a niche clinical application.
LOE Approaching
Product approaching loss of exclusivity with minimal linked job opportunities, indicating a contracting or specialized commercial infrastructure.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
This product presents minimal career opportunities with zero linked job openings, reflecting its niche market status and LOE-approaching lifecycle stage. Professionals considering this asset should expect limited growth, smaller team structures, and focus on operational efficiency rather than expansion.
External Resources
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.